APA (7th ed.) Citation

Y, H., A, B., A, L., J, Y., Y, B., N, S., . . . D, E. (2025). Preclinical evaluation of lentiviral gene therapy for adenosine deaminase 2 deficiency (DADA2): Engraftment efficiency and biodistribution in humanised NBSGW mice. Gene therapy, 32(6), 664. https://doi.org/10.1038/s41434-025-00547-4

Chicago Style (17th ed.) Citation

Y, Hong, et al. "Preclinical Evaluation of Lentiviral Gene Therapy for Adenosine Deaminase 2 Deficiency (DADA2): Engraftment Efficiency and Biodistribution in Humanised NBSGW Mice." Gene Therapy 32, no. 6 (2025): 664. https://doi.org/10.1038/s41434-025-00547-4.

MLA (9th ed.) Citation

Y, Hong, et al. "Preclinical Evaluation of Lentiviral Gene Therapy for Adenosine Deaminase 2 Deficiency (DADA2): Engraftment Efficiency and Biodistribution in Humanised NBSGW Mice." Gene Therapy, vol. 32, no. 6, 2025, p. 664, https://doi.org/10.1038/s41434-025-00547-4.